Your browser doesn't support javascript.
loading
FDA Warns Against Using Needle-Free Injection Devices For Dermal Fillers.
Aschenbrenner, Diane S.
Affiliation
  • Aschenbrenner DS; Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch : diane.aschenbrenner@gmail.com .
Am J Nurs ; 122(2): 24-25, 2022 02 01.
Article in En | MEDLINE | ID: mdl-35085145
The Food and Drug Administration (FDA) has issued a safety communication to warn the public and health care professionals not to use needle-free devices for injection of dermal fillers. These devices are not approved by the FDA. FDA-approved dermal fillers are for prescription use only with a syringe and either a needle or cannula.Nurses should inform patients not to purchase any needle-free devices or products over the internet. Adverse effects from these devices should be reported to the FDA's MedWatch system.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Drug Administration Routes / Dermal Fillers / Injection Site Reaction Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Nurs Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Drug Administration Routes / Dermal Fillers / Injection Site Reaction Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Nurs Year: 2022 Document type: Article Country of publication: